Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000375847

Medchemexpress LLC Act-660602 | 1646267-59-5 | C20H20F6N8OS | 100 MG
SDP

Supplier:  Medchemexpress LLC HY151096100MG

Encompass_Preferred

ACT-660602 is an orally active antagonist of chemokine receptor (CXCR3) with an IC50 value of 204 nM. It inhibits T-cell migration and has shown efficacy in an acute lung injury model. This compound can be used for autoimmune diseases research.

  • Orally active antagonist of chemokine receptor (CXCR3)
  • Inhibits T-cell migration
  • Demonstrates efficacy in an acute lung injury model
  • Suitable for autoimmune diseases research
  • Exhibits selectivity for CXCR3 over hERG (IC50 18 μM)
  • Displays non-competitive binding to CXCL10 and CXCL11

Catalog No. 50-003-75847


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.